WallStreetZenWallStreetZen

NASDAQ: CGC
Canopy Growth Corp Stock

$3.21-0.08 (-2.43%)
Updated Mar 1, 2024
CGC Price
$3.21
Fair Value Price
N/A
Market Cap
$292.48M
52 Week Low
$3.15
52 Week High
$23.10
P/E
-0.2x
P/B
0.72x
P/S
1.71x
PEG
N/A
Dividend Yield
N/A
Revenue
$246.67M
Earnings
-$959.81M
Gross Margin
-14.1%
Operating Margin
-386.99%
Profit Margin
-386.2%
Debt to Equity
1.5
Operating Cash Flow
-$300M
Beta
1.46
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CGC Overview

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CGC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CGC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CGC is good value based on its book value relative to its share price (0.72x), compared to the US Drug Manufacturers - Specialty & Generic industry average (2.26x)
P/B vs Industry Valuation
CGC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CGC due diligence checks available for Premium users.

Be the first to know about important CGC news, forecast changes, insider trades & much more!

CGC News

Valuation

CGC fair value

Fair Value of CGC stock based on Discounted Cash Flow (DCF)
Price
$3.21
Fair Value
$140.49
Undervalued by
97.72%
CGC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CGC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.2x
Industry
59.58x
Market
36.17x

CGC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.72x
Industry
2.26x
CGC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CGC's financial health

Profit margin

Revenue
$59.0M
Net Income
-$163.0M
Profit Margin
-276.2%
CGC's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
CGC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.0B
Liabilities
$612.8M
Debt to equity
1.5
CGC's short-term assets ($296.48M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CGC's long-term liabilities ($443.09M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CGC's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CGC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$24.5M
Investing
-$459.4k
Financing
-$49.8M
CGC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CGC vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
CGC$292.48M-2.43%-0.20x0.72x
KMDA$285.59M+1.11%45.50x1.20x
AQST$283.09M+15.53%-21.20x-2.75x
LFCR$254.71M+0.60%-1.48x7.45x
PROC$336.22M+2.05%5.73x8.54x

Canopy Growth Stock FAQ

What is Canopy Growth's quote symbol?

(NASDAQ: CGC) Canopy Growth trades on the NASDAQ under the ticker symbol CGC. Canopy Growth stock quotes can also be displayed as NASDAQ: CGC.

If you're new to stock investing, here's how to buy Canopy Growth stock.

What is the 52 week high and low for Canopy Growth (NASDAQ: CGC)?

(NASDAQ: CGC) Canopy Growth's 52-week high was $23.10, and its 52-week low was $3.15. It is currently -86.1% from its 52-week high and 1.9% from its 52-week low.

How much is Canopy Growth stock worth today?

(NASDAQ: CGC) Canopy Growth currently has 91,114,604 outstanding shares. With Canopy Growth stock trading at $3.21 per share, the total value of Canopy Growth stock (market capitalization) is $292.48M.

Canopy Growth stock was originally listed at a price of $282.00 in May 24, 2018. If you had invested in Canopy Growth stock at $282.00, your return over the last 5 years would have been -98.86%, for an annualized return of -59.14% (not including any dividends or dividend reinvestments).

How much is Canopy Growth's stock price per share?

(NASDAQ: CGC) Canopy Growth stock price per share is $3.21 today (as of Mar 1, 2024).

What is Canopy Growth's Market Cap?

(NASDAQ: CGC) Canopy Growth's market cap is $292.48M, as of Mar 3, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Canopy Growth's market cap is calculated by multiplying CGC's current stock price of $3.21 by CGC's total outstanding shares of 91,114,604.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.